Purple Pill Patents Patents are crucial to major drug companies. When patents expire, prices and profits fall because generic drug makers are allowed to sell cheap copies. Lately, many drug companies are finding ways to extend their patents. NPR's Snigdha Prakash reports on the patent wars surrounding the blockbuster heartburn pill, Prilosec.
NPR logo

Purple Pill Patents

  • Download
  • <iframe src="https://www.npr.org/player/embed/1141924/141924" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Purple Pill Patents

Purple Pill Patents

Purple Pill Patents

  • Download
  • <iframe src="https://www.npr.org/player/embed/1141924/141924" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Patents are crucial to major drug companies. When patents expire, prices and profits fall because generic drug makers are allowed to sell cheap copies. Lately, many drug companies are finding ways to extend their patents. NPR's Snigdha Prakash reports on the patent wars surrounding the blockbuster heartburn pill, Prilosec.